Latest news with #TheCloroxCompany
Yahoo
08-08-2025
- Business
- Yahoo
J.P. Morgan Lowers PT on Clorox Company from $140 to $133, Keeps Hold Rating
The Clorox Company (NYSE:CLX) is one of the . On August 1, J.P. Morgan lowered its price target on The Clorox Company (NYSE:CLX) from $140 to $133, keeping its Hold rating on the stock. Andrea Faria Teixeira from J.P. Morgan reduced the price target on CLX following Q4 FY2025 results. The company posted adjusted earnings per share of $2.87, exceeding estimates by $0.66 per share. The revenue reached almost $2 billion, surpassing the estimated $1.94 billion. The sales were mainly driven by the increased ERP shipments. A financial analyst standing in front of a screen with the ratings of the company provided by the NRSRO. Teixeira slightly lowered the price target on CLX as the company suffered challenges from the divestiture of its Better Health Vitamins, Minerals, and Supplements business and an unfavourable price mix. The analyst holds the rating while remaining cautious as the company anticipates a transitory impact on sales and earnings in FY2026 due to the ERP system transition. Clorox projects earnings per share between $5.95-$6.30 in FY2026, which is just in line with the average consensus estimate of $6.20. The Clorox Company (NYSE:CLX) is a multinational manufacturer and marketer of consumer and professional products. The company operates through four segments, including Health and Wellness, Household, Lifestyle, and International. While we acknowledge the potential of CLX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30-07-2025
- Business
- Yahoo
Clorox Increases Quarterly Dividend to $1.24 Per Share
OAKLAND, Calif., July 30, 2025 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that its board of directors has declared an increase to its quarterly dividend from $1.22 to $1.24 per share on the company's common stock. The dividend is payable August 29, 2025, to shareholders of record as of the close of business on August 13, 2025. Clorox has a long history of providing value to its shareholders through regular dividend payments and annual dividend increases. About The Clorox Company The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Its trusted brands include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr® and Pine-Sol® as well as international brands such as Clorinda®, Chux® and Poett®. Headquartered in Oakland, California, since 1913, Clorox was one of the first in the U.S. to integrate sustainability into its business reporting. In 2025 the company was ranked No. 1 on Barron's 100 Most Sustainable Companies list for the third consecutive year. Visit to learn more. Media Investor Relationsinvestorrelations@ CLX-C View original content to download multimedia: SOURCE The Clorox Company Sign in to access your portfolio
Globe and Mail
19-06-2025
- Business
- Globe and Mail
Clorox's Innovation Strategy Elevates Everyday Essentials
Innovation sits at the core of The Clorox Company 's CLX strategy to remain competitive in a category dominated by global giants and cost-effective private labels. It focuses on consumer-centric innovation, wherein improvements in performance, sensory appeal and convenience are key levers. In third-quarter 2025, Clorox highlighted the success of several premium products such as Scentiva disinfecting sprays, the upgraded ToiletWand and odor-control litter, all designed to command a premium while meeting real, evolving consumer needs. This strategy aligns with the company's belief that consumers are still willing to pay more for products that deliver superior value per use. Clorox's approach to innovation is both bifurcated and realistic. On one hand, the company is leaning into premiumization across categories to differentiate from private label. On the other hand, it is expanding price-pack architecture to provide budget-conscious consumers with flexible options, such as smaller entry-price packs and value sizes for club and mass channels. Clorox has been disciplined in its promotional strategy, choosing to support innovation through targeted marketing and selective discounting rather than broad-based price cuts. This dual approach allows the company to protect margins while defending its share across income segments and competitive environments. Looking ahead, Clorox remains committed to investing in R&D, supported by tools like its digital transformation and upcoming ERP system upgrade, which will enable more agile innovation and supply chain responsiveness. Despite current market headwinds and volatility in consumer spending, the company sees innovation as a key driver of long-term growth and margin expansion. Clorox's track record of delivering trustworthy, high-performing products in essential categories uniquely positions it to win in both up and down cycles, provided the company continues to innovate where it matters most to consumers. Clorox's Competitors in Innovation: PG,CL & CHD's Smart Moves The Procter & Gamble Company PG, Colgate-Palmolive Company CL and Church & Dwight Co., Inc. CHD are the key consumer staple companies competing with Clorox in the global arena. Procter & Gamble uses a smart strategy when it comes to innovation. The company keeps improving its popular brands like Tide, Febreze and Mr. Clean by adding new features, better scents or easier packaging. At the same time, PG gives shoppers different choices depending on their budget. Colgate focuses on value-driven innovation, especially in home care and personal hygiene. The company regularly updates products with new scents, improved cleaning formulas and convenient packaging. Colgate also invests in sustainability, such as recyclable bottles and concentrated products. Its innovation is often designed to meet the needs of both budget-conscious and environmentally aware consumers. Church & Dwight is a key competitor to Clorox, known for its value-focused and niche household brands like OxiClean and Arm & Hammer. The company emphasizes cost-effective innovation, often targeting specific consumer needs with affordable, functional products. CHD competes directly with Clorox in laundry additives, cleaning sprays, and baking soda-based solutions. CLX's Price Performance, Valuation & Estimates Clorox shares have lost 25.5% year to date compared with the industry's growth of 2.2%. From a valuation standpoint, CLX trades at a forward price-to-earnings ratio of 18.0X, significantly below the industry's average of 20.23X. The Zacks Consensus Estimate for CLX's 2025 earnings implies year-over-year growth of 14.9%, whereas its 2026 earnings estimate suggests a year-over-year decline of 5.4%. The estimates for 2025 and 2026 have been unchanged in the past 30 days. Image Source: Zacks Investment Research CLX currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Only $1 to See All Zacks' Buys and Sells We're not kidding. Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent. Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators, and more, that closed 256 positions with double- and triple-digit gains in 2024 alone. See Stocks Now >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Procter & Gamble Company (The) (PG): Free Stock Analysis Report Colgate-Palmolive Company (CL): Free Stock Analysis Report The Clorox Company (CLX): Free Stock Analysis Report Church & Dwight Co., Inc. (CHD): Free Stock Analysis Report
Yahoo
12-05-2025
- Business
- Yahoo
Clorox Announces Election of Gina Boswell to its Board of Directors
OAKLAND, Calif., May 12, 2025 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced the election of Gina Boswell to its board of directors, effective May 19, 2025. Boswell, 62, is the chief executive officer of Bath & Body Works, Inc., and also serves on its board. Her extensive leadership and operational experience also includes prior senior roles with Unilever, Avon, Ford and Estée Lauder. Boswell's deep consumer goods sector background across retail, marketing, brand building, business development, operations and innovation enables her to provide valuable perspective on Clorox's business strategy and growth. Boswell also has extensive public company board experience, having previously served on the boards of ACCO Brands Corporation, Manpower Group, Inc., and Wolverine Worldwide, Inc. "Gina's exceptional consumer experience is a tremendous asset to Clorox, and we are honored to have her on our board," said Linda Rendle, chair and chief executive officer of The Clorox Company. "Her global expertise in driving growth and innovation will serve us well as we deliver superior value for our consumers and consistent, profitable growth for our shareholders." Boswell's appointment will bring the number of Clorox board members to 12. Additional information about The Clorox Company board of directors can be found at About The Clorox CompanyThe Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Its trusted brands include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr® and Pine-Sol® as well as international brands such as Clorinda®, Chux® and Poett®. Headquartered in Oakland, California, since 1913, Clorox was one of the first in the U.S. to integrate ESG into its business reporting. In 2025 the company was ranked No. 1 on Barron's 100 Most Sustainable Companies list for the third consecutive year. Visit to learn more. CLX-F View original content to download multimedia: SOURCE The Clorox Company
Yahoo
25-04-2025
- Business
- Yahoo
The Clorox Company (CLX): Among the Growing Dividend Stocks with Low PE Ratios
We recently published a list of the . In this article, we are going to take a look at where The Clorox Company (NYSE:CLX) stands against other growing dividend stocks. Value stocks are enjoying a rare period of strength amid this year's broader market downturn. With earnings season approaching, it remains to be seen whether their recent edge over high-growth stocks will hold. The S&P Value Index—which includes sectors like banking, consumer staples, and healthcare, featuring companies that trade at relatively low valuations—has fallen around 9% this year. That's a smaller drop compared to the more than 15% decline seen in the growth-focused counterpart. Concerns over steep valuations in the tech sector, coupled with a wave of risk aversion triggered by tariffs, have pushed investors to shift from growth to value. While similar shifts haven't lasted long in the past, some investors believe that this time could be different, as expectations for value-oriented firms are modest enough that they may exceed them when earnings reports begin next month. Dan Morgan, senior portfolio manager at Synovus Trust, made the following comment about value investing: 'The bar has been set pretty low for value stocks compared to the uncertainty surrounding growth names and their ability to deliver on earnings estimates. If value can at least match or slightly beat expectations, the runway is clear for them.' According to data from Bloomberg Intelligence, analysts are forecasting a 12% decline in first-quarter earnings for value companies compared to the same period last year, while growth companies are expected to post a 20% increase. Supporters of value stocks believe that these lower expectations are already factored into their relatively modest valuations. On the other hand, optimism surrounding growth stocks—particularly in the tech sector—has soared in recent years, largely driven by enthusiasm over advancements in artificial intelligence. Historically, value stocks have lagged behind. Over the past 20 years, the S&P 500 Value Index has only outperformed its growth counterpart five times on an annual basis. During that period, the value index climbed 202%, while the growth index surged by 600%. Michael O'Rourke, chief market strategist at JonesTrading Institutional Services, made the following statement: 'Growth is about 40% more expensive; this outperformance of value was very long overdue. Due to the incredible strength of the Magnificent Seven, too many investors crowded into growth thinking it won't correct.' Investors often turn to dividend stocks when looking at companies with lower valuations. Dan Lefkovitz, a strategist at Morningstar Indexes, pointed out that dividend-growth stocks—those known for consistently raising their payouts—have underperformed the broader market in 2024. He attributed this to a market that has largely been driven by a handful of fast-growing tech names. However, he also remarked that while dividend-paying stocks may trail during such growth-led rallies, they tend to hold up better during market downturns, as seen in 2022 and 2018. Companies that consistently raise their dividends are often both profitable and financially stable—traits that become especially important during times of economic downturn. A team of professionals prepping for a training seminar, using professional cleaning products produced by the company. For this list, we focused on dividend-paying companies that have consistently paid dividends over the years and have also demonstrated a track record of increasing their payouts. From that group, we considered stocks with forward P/E ratios below 25, as of April 22. The stocks are ranked in ascending order of their P/E ratios. At Insider Monkey, we are obsessed with hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). Forward P/E Ratio as of April 22: 18.76 The Clorox Company (NYSE:CLX) is an American company that specializes in the manufacturing and marketing of consumer and professional products. The company's strong market position is closely tied to its close partnerships with major retailers. Walmart alone makes up about 25% of the company's sales, and the top five customers collectively generate nearly half of its total revenue. Although this level of customer concentration could be viewed as a potential risk, it actually gives Clorox significant bargaining power. These relationships help the company gain premium shelf space, run cross-brand promotions, and collaborate on marketing efforts—advantages that are difficult for rivals to replicate. In fiscal Q2 2025, The Clorox Company (NYSE:CLX) reported revenue of $1.7 billion, which fell by 15.2% from the same period last year. However, the revenue beat analysts' estimates by $60 million. Gross margin rose by 30 basis points, reaching 43.8% compared to 43.5% in the same quarter last year. This improvement was mainly due to cost-saving initiatives and the positive impact of selling off the VMS and Argentina operations. However, these gains were somewhat offset by lower cost absorption and increased expenses related to manufacturing, logistics, and raw materials. The Clorox Company (NYSE:CLX)'s cash position remained strong. Year-to-date, the company generated $401 million in operating cash flow, which showed 132% growth from the prior-year period. The company currently offers a quarterly dividend of $1.22 per share and has a dividend yield of 3.44%, as of April 22. It has been growing its dividends for 22 consecutive years. Overall, CLX ranks 23rd on our list of the best growing dividend stocks with low P/E ratios. While we acknowledge the potential of CLX as an investment, our conviction lies in the belief that some deeply undervalued dividend stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for a deeply undervalued dividend stock that is more promising than CLX but that trades at 10 times its earnings and grows its earnings at double digit rates annually, check out our report about the . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at .
